secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRISPR Therapeutics AG (CRSP)
CIK:        0001674416
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0000950170-25-045232
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRSP COO Julianne Bruno steps down effective April 11, 2025
-----------------------------------------------------------

- Julianne Bruno resigns as COO of CRISPR Therapeutics to pursue external opportunities.
- Departure effective April 11, 2025; she remains an employee until that date.
- Resignation not the result of any disagreement with the company.
- CEO Samarth Kulkarni thanked Bruno for six years of leadership in hematology and oncology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674416/000095017025045232/0000950170-25-045232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674416/000095017025045232/crsp-20250324.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-045232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer